In relapsing–remitting multiple sclerosis (RRMS), the cerebellum is a known predilection site for atrophy. Neuromyelitis optica (NMO) is characterized by extensive lesions in the spinal cord and optic nerve; however, cerebellar involvement has been less studied. Secondary degeneration of the spinocerebellar tract could impact the cerebellum in NMO.
Objective:
We aimed to investigate whether spinal cord and cerebellar volume measures differ between patients with NMO and RRMS.
Methods:
Volumetric analyses of the cerebellum (TCV), the upper cervical cord (UCV) as well as the whole brain (NBV) of age- and gender-matched patients with NMO (n=30; 56% AQP4 +ve) and RRMS (n=25) were performed on 3T brain magnetic resonance imaging (MRI) and compared with 34 healthy controls (HC).
Results:
UCV was significantly reduced in NMO patients (6.3 cm3) as compared with HC (6.7 cm3), while patients with MS had reduced brain volumes compared with HC (NBV=1482 cm3; p<0.001; TCV=188 cm3; p=0.042), but UCV close to normal values. Patients with RRMS and NMO differed in NBV (p=0.001; lower in RRMS) and by trend (towards reduction in RRMS) in cerebellar volume (p=0.06).
Conclusions:
While atrophy seems to be diffuse in MS patients, a rather focussed pattern with predominant involvement of the UCV was observed in NMO patients.
LennonVAWingerchukDMKryzerTJ. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet2004; 364: 2106–2112.
2.
LennonVAKryzerTJPittockSJ. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med2005; 202: 473–477.
3.
Amiry-MoghaddamMOttersenOP. The molecular basis of water transport in the brain. Nat Rev Neurosci2003; 4: 991–1001.
4.
WingerchukDMLennonVAPittockSJ. Revised diagnostic criteria for neuromyelitis optica. Neurology2006; 66: 1485–1489.
5.
RoccaMAAgostaFMezzapesaDM. Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica. Neurology2004; 62: 476–478.
6.
PichiecchioATavazziEPoloniG. Advanced magnetic resonance imaging of neuromyelitis optica: A multiparametric approach. Mult Scler2012; 18: 817–824.
7.
ChansonJBLamyJRousseauF. White matter volume is decreased in the brain of patients with neuromyelitis optica. Eur J Neurol2013; 20: 361–367.
8.
LiuYDuanYHeY. A tract-based diffusion study of cerebral white matter in neuromyelitis optica reveals widespread pathological alterations. Mult Scler2012; 18: 1013–1021.
9.
DuanYLiuYLiangP. Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: A voxel-based morphometry study. Eur J Radiol2012; 81: e110–e114.
10.
PolmanCHReingoldSCBanwellB. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol2011; 69: 292–302.
11.
KurtzkeJF. Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology1983; 33: 1444–1452.
12.
FischerJSRudickRACutterGR. The Multiple Sclerosis Functional Composite Measure (MSFC): An integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler1999; 5: 244–250.
13.
WeierKBeckAMagonS. Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosis. J Neurol2012; 259: 2673–2680.
SmithSMZhangYJenkinsonM. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage2002; 17: 479–489.
16.
SidakZ. Rectangular confidence regions for the means of multivariate normal distributions. J Am Stat Assoc1967; 62: 626–633.
17.
RoystonJP. An extension of Shapiro and Wilk’s W test for normality to large samples. J Royal Stat Soc Ser C (Appl Stat)1982; 31: 115–124.
18.
BrownMBForsytheAB. Robust tests for the equality of variances. J Am Stat Assoc1974; 69: 364–367.
19.
QuadeD. Rank analysis of covariance. J Am Stat Assoc1967; 62: 1187.
20.
FaulFErdfelderELangAG. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods2007; 39: 175–191.
21.
BenedettiBValsasinaPJudicaE. Grading cervical cord damage in neuromyelitis optica and MS by diffusion tensor MRI. Neurology2006; 67: 161–163.
22.
CalabreseMOhMSFavarettoA. No MRI evidence of cortical lesions in neuromyelitis optica. Neurology2012; 79: 1671–1676.
23.
BarkhofFFilippiMMillerDH. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain1997; 120: 2059–2069.
24.
MillerDHBarkhofFFrankJA. Measurement of atrophy in multiple sclerosis: Pathological basis, methodological aspects and clinical relevance. Brain2002; 125: 1676–1695.
25.
von GlehnFJariusSCavalcanti LiraRP. Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders. Mult Scler2014 [epub ahead of print].
26.
CalabreseMMattisiIRinaldiF. Magnetic resonance evidence of cerebellar cortical pathology in multiple sclerosis. J Neurol Neurosurg Psychiatry2010; 81: 401–404.
27.
RiveroRLOliveiraEMBichuettiDB. Diffusion tensor imaging of the cervical spinal cord of patients with neuromyelitis optica. Magn Reson Imaging2014; 32: 457–463.
QianWChanQMakH. Quantitative assessment of the cervical spinal cord damage in neuromyelitis optica using diffusion tensor imaging at 3 Tesla. J Magn Reson Imaging2011; 33: 1312–1320.
30.
CharilADagherALerchJP. Focal cortical atrophy in multiple sclerosis: Relation to lesion load and disability. Neuroimage2007; 34: 509–517.
31.
LuZZhangBQiuW. Comparative brain stem lesions on MRI of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis. PloS One2011; 6: e22766.
32.
MatthewsLMarascoRJenkinsonM. Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology2013; 80: 1330–1337.
33.
HuhSYMinJHKimW. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders. Mult Scler2014; 20: 695–704.
34.
LukasCSombekkeMHBellenbergB. Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients. Radiology2013; 269: 542–552.
